NR4A2 and neoplasm: Indeed, NR4A2/A1R engineered CAR T cells exhibited significantly increased expression of IFNγ, TNF and IL-2 secretion, primarily in CD8+ CAR T cells, following tumor cell coculture (Fig. 3D, E, and Supplementary Fig 6A).